ReP USP - Resultado da busca

Artigo de periodico
Cyclic ACTH-secreting thymic carcinoid: a case report and review of the literature (2021)
Lamback, Elisa B; Almeida, Sergio Altino de; Terra, Ricardo Mingarini ; Ferreira, Carlos Gil; Capelozzi, Vera Luiza ; Haddad, Rui; Gadelha, Monica R.
Source: Archives of endocrinology metabolism. Unidade: FM
Subjects: NEOPLASIAS DO TIMO, DIAGNÓSTICO POR IMAGEM, CORTISOL, TUMOR CARCINOIDE, RECIDIVA LOCAL DE NEOPLASIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAMBACK, Elisa B et al. Cyclic ACTH-secreting thymic carcinoid: a case report and review of the literature. Archives of endocrinology metabolism, v. 65, n. 4, p. 512-516, 2021Tradução . . Disponível em: https://doi.org/10.20945/2359-3997000000346. Acesso em: 09 nov. 2024.
APA
Lamback, E. B., Almeida, S. A. de, Terra, R. M., Ferreira, C. G., Capelozzi, V. L., Haddad, R., & Gadelha, M. R. (2021). Cyclic ACTH-secreting thymic carcinoid: a case report and review of the literature. Archives of endocrinology metabolism, 65( 4), 512-516. doi:10.20945/2359-3997000000346
NLM
Lamback EB, Almeida SA de, Terra RM, Ferreira CG, Capelozzi VL, Haddad R, Gadelha MR. Cyclic ACTH-secreting thymic carcinoid: a case report and review of the literature [Internet]. Archives of endocrinology metabolism. 2021 ; 65( 4): 512-516.[citado 2024 nov. 09 ] Available from: https://doi.org/10.20945/2359-3997000000346
Vancouver
Lamback EB, Almeida SA de, Terra RM, Ferreira CG, Capelozzi VL, Haddad R, Gadelha MR. Cyclic ACTH-secreting thymic carcinoid: a case report and review of the literature [Internet]. Archives of endocrinology metabolism. 2021 ; 65( 4): 512-516.[citado 2024 nov. 09 ] Available from: https://doi.org/10.20945/2359-3997000000346
Artigo de periodico
Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer (2020)
Parra, Edwin Roger; Jiang, Mei; Machado-rugolo, Juliana; Yaegashi, Lygia Bertalha; Prieto, Tabatha; Farhat, Cecília; Sá, Vanessa Karen de; Nagai, Maria Aparecida ; Lima, Vladmir Cláudio Cordeiro de; Takagaki, Teresa Yae; Terra, Ricardo Mingarini ; Fabro, Alexandre Todorovic ; Capelozzi, Vera Luiza
Source: Archives of Pathology & Laboratory Medicine. Unidades: FM, FMRP, FSP
Subjects: ANTÍGENOS, CARCINOMA, PULMÃO, NEOPLASIAS PULMONARES, LINFÓCITOS, IMUNOLOGIA, TAXA DE SOBREVIVÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARRA, Edwin Roger et al. Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer. Archives of Pathology & Laboratory Medicine, v. 144, n. 10, p. 1234-1244, 2020Tradução . . Disponível em: https://doi.org/10.5858/arpa.2019-0419-OA. Acesso em: 09 nov. 2024.
APA
Parra, E. R., Jiang, M., Machado-rugolo, J., Yaegashi, L. B., Prieto, T., Farhat, C., et al. (2020). Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer. Archives of Pathology & Laboratory Medicine, 144( 10), 1234-1244. doi:10.5858/arpa.2019-0419-OA
NLM
Parra ER, Jiang M, Machado-rugolo J, Yaegashi LB, Prieto T, Farhat C, Sá VK de, Nagai MA, Lima VCC de, Takagaki TY, Terra RM, Fabro AT, Capelozzi VL. Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer [Internet]. Archives of Pathology & Laboratory Medicine. 2020 ; 144( 10): 1234-1244.[citado 2024 nov. 09 ] Available from: https://doi.org/10.5858/arpa.2019-0419-OA
Vancouver
Parra ER, Jiang M, Machado-rugolo J, Yaegashi LB, Prieto T, Farhat C, Sá VK de, Nagai MA, Lima VCC de, Takagaki TY, Terra RM, Fabro AT, Capelozzi VL. Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer [Internet]. Archives of Pathology & Laboratory Medicine. 2020 ; 144( 10): 1234-1244.[citado 2024 nov. 09 ] Available from: https://doi.org/10.5858/arpa.2019-0419-OA
Artigo de periodico
Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer (2019)
Machado-rugolo, Juliana; Fabro, Alexandre Todorovic ; Ascheri, Daniel; Farhat, Cecilia; Ab'saber, Alexandre Muxfeldt; Sa, Vanessa Karen de; Nagai, Maria Aparecida; Takagaki, Teresa; Terra, Ricardo; Parra, Edwin Roger; Capelozzi, Vera Luiza
Source: Human pathology. Unidades: FM, FMRP
Subjects: NEOPLASIAS CEREBRAIS, METÁSTASE NEOPLÁSICA, NEOPLASIAS PULMONARES, IMUNOHISTOQUÍMICA, SEQUENCIAMENTO GENÉTICO, ONCOGENES, GENES SUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO-RUGOLO, Juliana et al. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer. Human pathology, v. 83, p. 177-191, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.humpath.2018.08.026. Acesso em: 09 nov. 2024.
APA
Machado-rugolo, J., Fabro, A. T., Ascheri, D., Farhat, C., Ab'saber, A. M., Sa, V. K. de, et al. (2019). Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer. Human pathology, 83, 177-191. doi:10.1016/j.humpath.2018.08.026
NLM
Machado-rugolo J, Fabro AT, Ascheri D, Farhat C, Ab'saber AM, Sa VK de, Nagai MA, Takagaki T, Terra R, Parra ER, Capelozzi VL. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer [Internet]. Human pathology. 2019 ; 83 177-191.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.humpath.2018.08.026
Vancouver
Machado-rugolo J, Fabro AT, Ascheri D, Farhat C, Ab'saber AM, Sa VK de, Nagai MA, Takagaki T, Terra R, Parra ER, Capelozzi VL. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer [Internet]. Human pathology. 2019 ; 83 177-191.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.humpath.2018.08.026
Artigo de periodico
A modified experimental model of malignant pleural disease induced by lung Lewis carcinoma (LLC) cells (2015)
Acencio, Milena Pagliarelli; Puka, Juliana; Marchi, Evaldo; Antonangelo, Leila; Terra, Ricardo; Vargas, Francisco Suso; Capelozzi, Vera Luiza; Teixeira, Lisete Ribeiro
Source: Journal of Translational Medicine. Unidade: FM
Subjects: CARICOMA, NEOPLASIAS PULMONARES, NEOPLASIAS POR LOCALIZAÇÃO, NEOPLASIAS PLEURAIS, NEOPLASIAS EXPERIMENTAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ACENCIO, Milena Pagliarelli et al. A modified experimental model of malignant pleural disease induced by lung Lewis carcinoma (LLC) cells. Journal of Translational Medicine, v. 13, p. 8 art. 302, 2015Tradução . . Disponível em: https://doi.org/10.1186/s12967-015-0662-2. Acesso em: 09 nov. 2024.
APA
Acencio, M. P., Puka, J., Marchi, E., Antonangelo, L., Terra, R., Vargas, F. S., et al. (2015). A modified experimental model of malignant pleural disease induced by lung Lewis carcinoma (LLC) cells. Journal of Translational Medicine, 13, 8 art. 302. doi:10.1186/s12967-015-0662-2
NLM
Acencio MP, Puka J, Marchi E, Antonangelo L, Terra R, Vargas FS, Capelozzi VL, Teixeira LR. A modified experimental model of malignant pleural disease induced by lung Lewis carcinoma (LLC) cells [Internet]. Journal of Translational Medicine. 2015 ; 13 8 art. 302.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1186/s12967-015-0662-2
Vancouver
Acencio MP, Puka J, Marchi E, Antonangelo L, Terra R, Vargas FS, Capelozzi VL, Teixeira LR. A modified experimental model of malignant pleural disease induced by lung Lewis carcinoma (LLC) cells [Internet]. Journal of Translational Medicine. 2015 ; 13 8 art. 302.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1186/s12967-015-0662-2
Trabalho de evento-resumo periodico
An useful experimental model of malignant pleural disease induced by Lewis lung cancer (LLC) cells (2014)
Teixeira, Lisete Ribeiro; Capelozzi, Vera Luiza; Acencio, Milena Marques Pagliari; Marchi, Evaldo; Puka, Juliana; Vargas, Francisco Suso; Silva, Juliana Sanchez; Terra, Ricardo Mingarini; Antonangelo, Leila
Source: Journal of Thoracic Oncology. Conference titles: IASLC Latin American Conference Lung Cancer. Unidade: FM
Subjects: CÉLULAS CULTIVADAS DE TUMOR, DERRAME PLEURAL MALIGNO, NEOPLASIAS PULMONARES, RESUMOS/EVENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA, Lisete Ribeiro et al. An useful experimental model of malignant pleural disease induced by Lewis lung cancer (LLC) cells. Journal of Thoracic Oncology. Hagerstown: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 09 nov. 2024. , 2014
APA
Teixeira, L. R., Capelozzi, V. L., Acencio, M. M. P., Marchi, E., Puka, J., Vargas, F. S., et al. (2014). An useful experimental model of malignant pleural disease induced by Lewis lung cancer (LLC) cells. Journal of Thoracic Oncology. Hagerstown: Faculdade de Medicina, Universidade de São Paulo.
NLM
Teixeira LR, Capelozzi VL, Acencio MMP, Marchi E, Puka J, Vargas FS, Silva JS, Terra RM, Antonangelo L. An useful experimental model of malignant pleural disease induced by Lewis lung cancer (LLC) cells. Journal of Thoracic Oncology. 2014 ; 9( 9): S200.[citado 2024 nov. 09 ]
Vancouver
Teixeira LR, Capelozzi VL, Acencio MMP, Marchi E, Puka J, Vargas FS, Silva JS, Terra RM, Antonangelo L. An useful experimental model of malignant pleural disease induced by Lewis lung cancer (LLC) cells. Journal of Thoracic Oncology. 2014 ; 9( 9): S200.[citado 2024 nov. 09 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em